Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 7.

Gössi, F; Spahn, M; Zweifel, M; Panagiotis, S; Mischo, A; Stenner, F; Hess, U; Berthold, D; Bargetzi, M; Schardt, J; Pabst, T (2017). Comparison of three or fewer high-dose chemotherapy cycles as salvage treatment in germ cell tumors in first relapse. Bone Marrow Transplantation, 52(2):334-336.

Meissner, J; Finel, H; Dietrich, S; Boumendil, A; Kanfer, E; Laboure, G; Abecasis, M; Cornelissen, J; Delage, J; Finke, J; Hess, U; Ludwig, H; Mohty, M; Pabst, T; Pioltelli, P; Robinson, S; Samaras, P; Montoto, S; Dreger, P (2017). Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience. Bone Marrow Transplantation, 52(4):650-652.

Cornelissen, J J; Versluis, J; Passweg, J R; van Putten, W L; Manz, M G; Maertens, J; Beverloo, H B; Valk, P J; van Marwijk, Kooy M; Wijermans, P W; Schaafsma, M R; Biemond, B J; Vekemans, M C; Breems, D A; Verdonck, L F; Fey, M F; Jongen-Lavrencic, M; Janssen, J J; Huls, G; Kuball, J; Pabst, T; Graux, C; Schouten, H C; Gratwohl, A; Vellenga, E; Ossenkoppele, G; Löwenberg, B (2015). Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years. Leukemia, 29(5):1041-1050.

Terwijn, M; van Putten, W L; Kelder, A; van der Velden, V H; Brooimans, R A; Pabst, T; Maertens, J; Boeckx, N; de Greef, G E; Valk, P J; Preijers, F W; Huijgens, P C; Dräger, A M; Schanz, U; Jongen-Lavrecic, M; Biemond, B J; Passweg, J R; van Gelder, M; Wijermans, P; Graux, C; Bargetzi, M; Legdeur, M C; Kuball, J; de Weerdt, O; Chalandon, Y; Hess, U; Verdonck, L F; Gratama, J W; Oussoren, Y J; Scholten, W J; Slomp, J; Snel, A N; Vekemans, M C; Löwenberg, B; Ossenkoppele, G J; Schuurhuis, G J (2013). High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: Data from the HOVON/SAKK AML 42A Study. Journal of Clinical Oncology, 31(31):3889-3897.

Passweg, J R; Baldomero, H; Bargetzi, M; Bucher, C; Chalandon, Y; Duchosal, M A; Gratwohl, A; Güngör, T; Hess, U; Leibundgut, K; de Faveri, G N; Ozsahin, H; Pabst, T; Renner, C; Stern, M; Stussi, G; Schanz, U (2013). Haematopoietic stem cell transplantation: activity in Switzerland compared with surrounding European countries. Swiss Medical Weekly, 143:w13757.

Löwenberg, B; Pabst, T; Vellenga, E; van Putten, W; Schouten, H C; Graux, C; Ferrant, A; Sonneveld, P; Biemond, B J; Gratwohl, A; de Greef, G E; Verdonck, L F; Schaafsma, M R; Gregor, M; Theobald, M; Schanz, U; Maertens, J; Ossenkoppele, G J (2011). Cytarabine dose for acute myeloid leukemia. New England Journal of Medicine, 364(11):1027-1036.

Lugthart, S; Gröschel, S; Beverloo, H B; Kayser, S; Valk, P J; van Zelderen-Bhola, S L; Ossenkoppele, G J; Vellenga, E; van den Berg-de Ruiter, E; Schanz, U; Verhoef, G; Vandenberghe, P; Ferrant, A; Köhne, C H; Pfreundschuh, M; Horst, H A; Schlegelberger, H; Jotterand, M; Krauter, J; Pabst, T; Theobald, M; Schlenk, R F; Delwel, R; Döhner, K; Löwenberg, B; Döhner, H (2010). Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia. Journal of Clinical Oncology, 28(24):3890-3899.

This list was generated on Mon Jun 17 05:09:11 2019 CEST.